ARNA - Arena Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 52.68B
Enterprise Value 31.73B
Trailing P/E 4.57
Forward P/E 1-9.39
PEG Ratio (5 yr expected) 1-0.33
Price/Sales (ttm)3.29
Price/Book (mrq)2.23
Enterprise Value/Revenue 32.12
Enterprise Value/EBITDA 62.92

Trading Information

Stock Price History

Beta (3Y Monthly) 1.07
52-Week Change 348.64%
S&P500 52-Week Change 30.90%
52 Week High 364.48
52 Week Low 331.97
50-Day Moving Average 359.31
200-Day Moving Average 352.70

Share Statistics

Avg Vol (3 month) 3516.28k
Avg Vol (10 day) 3392.31k
Shares Outstanding 549.57M
Float 49.76M
% Held by Insiders 10.16%
% Held by Institutions 185.23%
Shares Short (Jul 31, 2019) 43.18M
Short Ratio (Jul 31, 2019) 47.84
Short % of Float (Jul 31, 2019) 46.42%
Short % of Shares Outstanding (Jul 31, 2019) 46.38%
Shares Short (prior month Jun 28, 2019) 43.28M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 210/1
Last Split Date 3Jun 19, 2017

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019


Profit Margin 72.84%
Operating Margin (ttm)72.44%

Management Effectiveness

Return on Assets (ttm)38.36%
Return on Equity (ttm)67.41%

Income Statement

Revenue (ttm)814.3M
Revenue Per Share (ttm)16.45
Quarterly Revenue Growth (yoy)-74.40%
Gross Profit (ttm)-97.06M
EBITDA 593.29M
Net Income Avi to Common (ttm)593.13M
Diluted EPS (ttm)11.76
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.01B
Total Cash Per Share (mrq)20.19
Total Debt (mrq)58.84M
Total Debt/Equity (mrq)4.90
Current Ratio (mrq)36.51
Book Value Per Share (mrq)24.11

Cash Flow Statement

Operating Cash Flow (ttm)617.83M
Levered Free Cash Flow (ttm)397.23M